16-2116896-C-T
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM1PM2PM5PP3_StrongPP5
The NM_001009944.3(PKD1):c.1543G>A(p.Gly515Arg) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G515W) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001009944.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PKD1 | NM_001009944.3 | c.1543G>A | p.Gly515Arg | missense_variant | 7/46 | ENST00000262304.9 | NP_001009944.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PKD1 | ENST00000262304.9 | c.1543G>A | p.Gly515Arg | missense_variant | 7/46 | 1 | NM_001009944.3 | ENSP00000262304.4 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 7.27e-7 AC: 1AN: 1375178Hom.: 0 Cov.: 29 AF XY: 0.00000147 AC XY: 1AN XY: 680114
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Polycystic kidney disease, adult type Pathogenic:2Uncertain:1
Pathogenic, criteria provided, single submitter | clinical testing | Mendelics | May 04, 2022 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Apr 20, 2020 | The PKD1 c.1543G>A; p.Gly515Arg variant (rs1555458704) is reported in the literature in an individual affected with autosomal dominant polycystic kidney disease (Chang 2013). This variant is absent from general population databases (Exome Variant Server, Genome Aggregation Database), indicating it is not a common polymorphism. The glycine at codon 515 is moderately conserved, and computational analyses (SIFT, PolyPhen-2) predict that this variant is deleterious. Additionally, another amino acid substitution at this codon (p.Gly515Trp) has been reported in multiple individuals with autosomal dominant polycystic kidney disease, although it has not been conclusively demonstrated to cause disease (Cornec-Le Gall 2013, Kim 2019). Due to limited information, the clinical significance of the p.Gly515Arg variant is uncertain at this time. References: Chang MY et al. Novel PKD1 and PKD2 mutations in Taiwanese patients with autosomal dominant polycystic kidney disease. J Hum Genet. 2013 Nov;58(11):720-7. Cornec-Le Gall E et al. Type of PKD1 mutation influences renal outcome in ADPKD. J Am Soc Nephrol. 2013 May;24(6):1006-13. Kim H et al. Genetic Characteristics of Korean Patients with Autosomal Dominant Polycystic Kidney Disease by Targeted Exome Sequencing. Sci Rep. 2019 Nov 18;9(1):16952. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Eurofins-Biomnis | Sep 23, 2022 | - - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jan 08, 2024 | Reported as one of several PKD1 variants (phase unknown) in a patient with polycystic kidney disease in published literature (PMID: 23985799); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on splicing and protein structure/function; This variant is associated with the following publications: (PMID: 23985799) - |
PKD1-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 30, 2023 | The PKD1 c.1543G>A variant is predicted to result in the amino acid substitution p.Gly515Arg. This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. This variant has been reported in an individual with autosomal dominant polycystic kidney disease (ADPKD) (Chang et al. 2013. PubMed ID: 23985799). In addition, we have found this variant in the heterozygous state in multiple presumably unrelated patients tested for cystic kidney disease at PreventionGenetics (internal data). Of note, a different substitution at the same codon define as c.1543G>T (p.Gly515Trp) has been reported in presumably unrelated individuals with polycystic kidney disease (Cornec-Le Gall et al. 2013. PubMed ID: 23431072, Suppl. Table 1; Domingo-Gallego et al. 2021. PubMed ID: 33532864, Suppl. Table 2; Kim et al. 2019. PubMed ID: 31740684, Suppl. Table S6C). This c.1543G>A (p.Gly515Arg) variant is interpreted as pathogenic. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jul 14, 2017 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at